Filing Details

Accession Number:
0001062993-10-003047
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-09-15 16:43:52
Reporting Period:
2010-09-13
Filing Date:
2010-09-15
Accepted Time:
2010-09-15 16:43:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875622 Biospecifics Technologies Corp BSTC Pharmaceutical Preparations (2834) 113054851
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1355189 Thomas Wegman 1764 Briar Place
Merrick NY 11566
President Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Disposition 2010-09-13 150,000 $23.50 1,005,179 No 4 S Indirect Held by the Estate of Edwin H. Wegman
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Held by the Estate of Edwin H. Wegman
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.001 Par Value 113,644 Direct
Common Stock, $0.001 Par Value 7,300 Indirect Held by spouse and son
Footnotes
  1. The Reporting Person is an executor and beneficiary of the Estate of Edwin H. Wegman (the "Estate") and is therefore deemed to beneficially own shares of the Issuer's common stock that are held by the Estate. On September 13, 2010, the Estate sold 150,000 shares of the Issuer's common stock in a private transaction.